Larson Financial Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35K | Hold |
1,647
| – | – | ﹤0.01% | 1213 |
|
|
2025
Q1 | $31.8K | Hold |
1,647
| – | – | ﹤0.01% | 1184 |
|
|
2024
Q4 | $29.4K | Hold |
1,647
| – | – | ﹤0.01% | 1074 |
|
|
2024
Q3 | $36.1K | Hold |
1,647
| – | – | ﹤0.01% | 996 |
|
|
2024
Q2 | $12.8K | Hold |
1,647
| – | – | ﹤0.01% | 1187 |
|
|
2024
Q1 | $6.82K | Hold |
1,647
| – | – | ﹤0.01% | 1128 |
|
|
2023
Q4 | $4.3K | Hold |
1,647
| – | – | ﹤0.01% | 1217 |
|
|
2023
Q3 | $3.08K | Hold |
1,647
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q2 | $4.13K | Hold |
1,647
| – | – | ﹤0.01% | 1140 |
|
|
2023
Q1 | $2.88K | Hold |
1,647
| – | – | ﹤0.01% | 1188 |
|
|
2022
Q4 | $7K | Buy |
+1,647
| New | +$7K | ﹤0.01% | 959 |
|
|
2019
Q4 | – | Sell |
-654
| Closed | -$1K | – | 656 |
|
|
2019
Q3 | $1K | Hold |
654
| – | – | ﹤0.01% | 513 |
|
|
2019
Q2 | $1K | Hold |
654
| – | – | ﹤0.01% | 464 |
|
|
2019
Q1 | $1K | Buy |
+654
| New | +$1K | ﹤0.01% | 460 |
|